DELRAY BEACH, Fla., & CHASKA, Minn.--(BUSINESS WIRE)--PositiveID Corporation (“PositiveID”) (NASDAQ:PSID) and its development partner RECEPTORS LLC (“Receptors”), a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today their intention to expand their exclusive license agreement to include Patent No. 7,504,364 titled “Methods of Making Arrays and Artificial Receptors” and Patent No. 7,469,076 “Sensors Employing Combinatorial Artificial Receptors,” to use in conjunction with PositiveID’s Patent No. 7,125,382 entitled “Embedded Bio-Sensor System” to develop an in vivo glucose-sensing radio frequency microchip for animals, primarily dogs and cats.
